Dongwha Pharm, Stock Price 22,550 Won (2.5%)... Bulletin Board 'Bustling'

At this time, posts about Dongwha Pharm are rapidly increasing on portals and stock communities. Today, foreigners have tentatively purchased a net 7,000 shares of Dongwha Pharm, and institutions have also net purchased 7,000 shares. Dongwha Pharm is known as a manufacturer and seller of pharmaceuticals (such as Gas Hwal Myeong Su and Fusidin).

As of 12:30 PM on the 19th, Dongwha Pharm's stock price is 22,550 KRW, up 2.5% from the previous day, with a trading volume of 1,894,758 shares, which is 39.12% of the 5-day average trading volume. On August 18, Dongwha Pharm became a market issue with the news of applying for Phase 2 clinical trials for the COVID-19 drug 'DW2008,' causing a surge in its stock price.

Besides Dongwha Pharm, posts about DNA Link (127120), SK Discovery (006120), and OQP (078590) are also rapidly increasing among investors.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.